Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT):: potatoes expressing a synthetic LT-B gene

被引:262
作者
Mason, HS
Haq, TA
Clements, JD
Arntzen, CJ
机构
[1] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA
[2] Texas A&M Inst Biosci & Technol, Houston, TX 77030 USA
[3] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA
关键词
potato; plant-vaccine; diarrhoeal-disease; enterotoxin-LT-B; E-coli; mouse;
D O I
10.1016/S0264-410X(98)80020-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The authors have designed and constructed a plant-optimized synthetic gene encoding the Escherichia coli heat-labile enterotoxin B subunit (LT-B), for use in transgenic plants as an edible vaccine against enterotoxigenic E, coli Expression of the synthetic LT-B gene in potato plants under the control of a constitutive promoter yielded increased accumulation of LT-B in leaves and tubers, as compared to the bacterial LT-B gene. The plant-derived LT-B assembled into native pentameric structures as evidenced by its ability to bind ganglioside. The authors demonstrated immunogenicity by feeding mice the raw tubers and comparing the anti-LT-B serum IgG and faecal IgA to that produced in mice gavaged with bacterial LT-B. Mice were fed three weekly doses of 5g tuber tissue containing either 20 or 50 mu g LT-B, or gavaged weekly with 5 mu g of LT-B from recombinant E, coli One week after the third nose, mice immunized with potato LT-B had higher levels of serum and mucosal anti-LT-B than those gavaged with bacterial LT-B. Mice were challenged by oral administration of 25 mu g LT and protection assessed by comparing the gut/carcass mass ratios, Although none of the mice were completely protected, the higher dose potato vaccine compared flavourably with the bacterial vaccine. These findings show that an edible vaccine against E, coli LT-B is feasible. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1336 / 1343
页数:8
相关论文
共 20 条
[1]   THE RECONSTRUCTION AND EXPRESSION OF A BACILLUS-THURINGIENSIS CRYIIIA GENE IN PROTOPLASTS AND POTATO PLANTS [J].
ADANG, MJ ;
BRODY, MS ;
CARDINEAU, G ;
EAGAN, N ;
ROUSH, RT ;
SHEWMAKER, CK ;
JONES, A ;
OAKES, JV ;
MCBRIDE, KE .
PLANT MOLECULAR BIOLOGY, 1993, 21 (06) :1131-1145
[2]   Gene expression patterns and cancer [J].
Szallasi, Z .
NATURE BIOTECHNOLOGY, 1998, 16 (13) :1292-1293
[3]  
Arntzen C., 1997, NEW GENERATION VACCI, V2nd, P263
[4]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP [J].
CLEMENS, JD ;
SACK, DA ;
HARRIS, JR ;
VANLOON, F ;
CHAKRABORTY, J ;
AHMED, F ;
RAO, MR ;
KHAN, MR ;
YUNUS, M ;
HUDA, N ;
STANTON, BF ;
KAY, BA ;
WALTER, S ;
EECKELS, R ;
SVENNERHOLM, AM ;
HOLMGREN, J .
LANCET, 1990, 335 (8684) :270-273
[5]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - SERUM VIBRIOCIDAL AND ANTITOXIC ANTIBODIES AS MARKERS OF THE RISK OF CHOLERA [J].
CLEMENS, JD ;
VANLOON, F ;
SACK, DA ;
CHAKRABORTY, J ;
RAO, MR ;
AHMED, F ;
HARRIS, JR ;
KHAN, MR ;
YUNUS, M ;
HUDA, S ;
KAY, BA ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1235-1242
[6]   CONSTRUCTION OF A POTENTIAL LIVE ORAL BIVALENT VACCINE FOR TYPHOID-FEVER AND CHOLERA-ESCHERICHIA-COLI-RELATED DIARRHEAS [J].
CLEMENTS, JD ;
ELMORSHIDY, S .
INFECTION AND IMMUNITY, 1984, 46 (02) :564-569
[7]   DISSOCIATION OF ESCHERICHIA-COLI HEAT-LABILE ENTEROTOXIN ADJUVANTICITY FROM ADP-RIBOSYLTRANSFERASE ACTIVITY [J].
DICKINSON, BL ;
CLEMENTS, JD .
INFECTION AND IMMUNITY, 1995, 63 (05) :1617-1623
[8]   Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin [J].
Guidry, JJ ;
Cardenas, L ;
Cheng, E ;
Clements, JD .
INFECTION AND IMMUNITY, 1997, 65 (12) :4943-4950
[9]   ORAL IMMUNIZATION WITH A RECOMBINANT BACTERIAL-ANTIGEN PRODUCED IN TRANSGENIC PLANTS [J].
HAQ, TA ;
MASON, HS ;
CLEMENTS, JD ;
ARNTZEN, CJ .
SCIENCE, 1995, 268 (5211) :714-716
[10]   Expression of cholera toxin subunits in plants [J].
Hein, MB ;
Yeo, TC ;
Wang, F ;
Sturtevant, A .
ENGINEERING PLANTS FOR COMMERCIAL PRODUCTS AND APPLICATIONS, 1996, 792 :50-56